Nucleic acid-based therapeutics are rapidly becoming a promising modality for the next generation of genetic medicine. Landmark Bio provides a range of services designed to help advance your nucleic acid-based drugs to the clinic.
From determining the appropriate scale and delivery vehicle for your nucleic acid cargo to large-scale manufacturing, our expertise ensures that your innovative therapies can reach their full potential.